Provided by Tiger Fintech (Singapore) Pte. Ltd.

Absci Corporation.

2.63
+0.07002.73%
Pre-market: 2.660.0300+1.14%06:25 EDT
Volume:3.88M
Turnover:10.33M
Market Cap:393.24M
PE:-2.79
High:2.73
Open:2.58
Low:2.56
Close:2.56
52wk High:6.33
52wk Low:2.01
Shares:149.52M
Float Shares:127.00M
Volume Ratio:0.80
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9428
EPS(LYR):-0.9353
ROE:-57.39%
ROA:-31.26%
PB:2.27
PE(LYR):-2.81

Loading ...

Absci Corporation to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Aug 20

Absci Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 18

Absci Second Quarter 2025 Earnings: Misses Expectations

Simply Wall St.
·
Aug 14

Absci files $400M mixed securities shelf

TIPRANKS
·
Aug 13

Absci Corp: Sales Agreement Prospectus Covering Offering of up to $100 Mln of Common Stock That May Be Issued From Time to Time

THOMSON REUTERS
·
Aug 13

Absci Corp Files for Mixed Shelf of up to $400 Mln – SEC Filing

THOMSON REUTERS
·
Aug 13

Absci Corp reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 13

Absci reports Q2 EPS (24c), consensus (21c)

TIPRANKS
·
Aug 13

Absci Corporation Unveils Presentation on AI-Driven Antibody Design and Clinical Pipeline Progress

Reuters
·
Aug 13

Absci Corporation Q2 2025 Results: Revenue Falls to $0.6M, Net Loss Widens to $30.6M

Reuters
·
Aug 13

Absci Q2 EPS $(0.24) Misses $(0.21) Estimate, Sales $593.000K Miss $1.427M Estimate

Benzinga
·
Aug 13

BRIEF-Absci Q2 Operating Income USD -31.393 Million

Reuters
·
Aug 13

Absci Corp - Anticipates Initiation of Phase 1/2a Clinical Trial for Abs-201 in Early 2026

THOMSON REUTERS
·
Aug 13

Absci Corp - NOW Believes Existing Cash, Cash Equivalents, Short-Term Investments Sufficient to Fund Operations Into H1 2028

THOMSON REUTERS
·
Aug 13

AbSci Corp options imply 11.5% move in share price post-earnings

TIPRANKS
·
Aug 13

Absci Corp expected to post a loss of 21 cents a share - Earnings Preview

Reuters
·
Aug 09

Spanish stocks - Factors to watch on Aug 7

Reuters
·
Aug 07

Almirall And Absci Expand AI Drug Creation Collaboration Adding Second Dermatology Target

Reuters
·
Aug 07

Absci Corporation and Almirall Expand AI Drug Discovery Partnership to Target Dermatological Conditions

Reuters
·
Aug 07

Almirall - Absci Eligible for up to $650 Mln in Payments

THOMSON REUTERS
·
Aug 07